Cellebrite DI (CLBT) Company Report

Analyst Coverage

Research analysts who have asked questions during Cellebrite DI earnings calls.

Jeff Van Rhee

Craig-Hallum Capital Group LLC

6 questions for CLBT

Also covers: AKAM, ALKT, ASUR +18 more

Shaul Eyal

TD Cowen

6 questions for CLBT

Also covers: ALLT, CGNT, CHKP +14 more

Eric Martinuzzi

Lake Street Capital Markets

5 questions for CLBT

Also covers: APEI, ASPU, ASUR +24 more

Bhavin Shah

Deutsche Bank

4 questions for CLBT

Also covers: ADSK, DAY, EVCM +4 more

Brian Essex

JPMorgan Chase & Co.

4 questions for CLBT

Also covers: AI, CHKP, CRWD +18 more

Jonathan Ho

William Blair & Company

4 questions for CLBT

Also covers: AKAM, ALLT, AXON +15 more

Tomer Zilberman

Bank of America

4 questions for CLBT

Also covers: EXTR, FFIV, FTNT +3 more

Michael Cikos

Needham & Company

3 questions for CLBT

Also covers: AI, BASE, BLZE +20 more

Mike Cikos

Needham & Company, LLC

3 questions for CLBT

Also covers: AKAM, BASE, BLZE +22 more

Louie DiPalma

William Blair

2 questions for CLBT

Also covers: AIR, ASTS, AVAV +16 more

Brad Zelnick

Credit Suisse

1 question for CLBT

Also covers: ADBE, CFLT, CHKP +20 more

Charlotte Bedick

JPMorgan Chase & Co.

1 question for CLBT

Also covers: CYBR, OKTA, QLYS

Maxwell Michaelis

Lake Street Capital Markets

1 question for CLBT

Also covers: APEI, BCOV, BLZE +10 more

Latest news

Recent press releases and 8-K filings for CLBT.

Cellebrite Reports Strong Q4 and Full-Year 2025 Results, Provides Optimistic 2026 Guidance, and Announces New Acquisition

CLBT

Earnings

Guidance Update

M&A

Cellebrite closed 2025 with 21% ARR growth to $481 million (17% organic growth) and 19% revenue growth to $475.7 million. The company generated $160 million in free cash flow, representing a 34% margin.
Strategic progress in 2025 included the acquisition of Corellium in December, which contributed $16.1 million to ARR, and the conversion of 55% of its digital forensics base to Inseyets. SaaS and cloud offerings saw ARR growth north of 50%, now comprising 22% of total ARR.
For 2026, Cellebrite provided initial guidance expecting ARR in the range of $567-$573 million (18%-19% growth) and revenue between $565-$571 million (19%-20% growth). Adjusted EBITDA is projected to be $149-$155 million (26%-27% margin), with Free Cash Flow margins anticipated to exceed 30%.
The company also announced an agreement to acquire SCG Canada, a drone forensics technology provider, expected to close by the end of Q1 2026, and plans to launch Guardian Investigate in spring 2026.

Feb 11, 2026, 1:30 PM

Transcript

Cellebrite DI Reports Strong Q4 2025 Results and Provides Optimistic 2026 Guidance

CLBT

Earnings

Guidance Update

M&A

Cellebrite closed 2025 with 21% ARR growth, reaching $481 million including Corellium, and 19% full-year revenue growth to $475.7 million. The company also achieved strong free cash flow of $160 million in 2025, representing a 34% margin.
For full fiscal year 2026, the company expects ARR in the range of $567-$573 million (18%-19% growth), revenue between $565-$571 million (19%-20% growth), and Adjusted EBITDA of $149-$155 million with a margin of 26%-27%.
Strategic progress in 2025 included converting 55% of the installed digital forensics base to Inseyets, exceeding the 50% target, and seeing SaaS and cloud offerings grow ARR north of 50%, now representing 22% of total ARR.
Cellebrite completed the acquisition of Corellium in early December 2025 and agreed to purchase SCG Canada, a drone forensics company, with the transaction expected to close by the end of Q1 2026. The U.S. federal segment is also anticipated to reaccelerate growth in 2026 after a roughly flat performance in 2025.

Feb 11, 2026, 1:30 PM

Transcript

Cellebrite DI Reports Q4 and Full Year 2025 Results, Announces Corellium Acquisition, and Provides FY26 Guidance

CLBT

Earnings

M&A

Guidance Update

Cellebrite DI reported Q4 2025 total revenue of $129 million, an 18% increase year-over-year, with subscription revenue growing 21% to $115 million. For the full year 2025, Annual Recurring Revenue (ARR) reached $481 million , total revenue was $476 million, and Adjusted EBITDA stood at $127.6 million.
The company completed the acquisition of Corellium in Q4 2025 for $170 million in cash, with the acquisition contributing $16.1 million to 2025 ARR.
For fiscal year 2026, Cellebrite DI expects ARR to be between $567 million and $573 million, revenue between $565 million and $571 million, and Adjusted EBITDA between $149 million and $155 million.

Feb 11, 2026, 1:30 PM

Presentation

Cellebrite Reports Strong Q4 and Full-Year 2025 Results, Provides 2026 Guidance

CLBT

Earnings

Guidance Update

M&A

Cellebrite reported strong financial results for Q4 and full-year 2025, with ARR growing 21% to $481 million and Free Cash Flow reaching $160 million (34% margin) for the full year.
For Q4 2025, revenue increased 18% to $128.8 million, and Adjusted EBITDA grew 33% to $38.3 million.
The company provided initial guidance for FY 2026, projecting ARR of $567-$573 million (18%-19% growth) and revenue of $565-$571 million (19%-20% growth).
Strategic achievements in 2025 included converting 55% of the digital forensics base to Inseyets and completing the acquisition of Corellium in December.
Cellebrite anticipates reaccelerated growth in 2026, driven by the U.S. federal segment, a 20% expansion in sales executives, and the agreement to acquire SCG Canada for drone forensics.

Feb 11, 2026, 1:30 PM

Transcript

Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results

CLBT

Earnings

Guidance Update

M&A

Cellebrite reported record fourth-quarter 2025 revenue of $128.8 million and full-year 2025 revenue of $475.7 million, representing 18% and 19% year-over-year growth, respectively.
Total Annual Recurring Revenue (ARR) increased 21% year-over-year to $480.8 million for Q4 2025.
For the full year 2025, GAAP net income was $78.3 million and Non-GAAP net income reached $130.5 million.
The company issued a Full-Year 2026 outlook, forecasting revenue between $565 million and $571 million and ARR between $567 million and $573 million.
Cellebrite announced the acquisition of SCG Canada Inc., a provider of drone forensics solutions, with the deal expected to close later this quarter.

Feb 11, 2026, 12:15 PM

6-K

Cellebrite Announces Fourth-Quarter and Full-Year 2025 Results and 2026 Outlook

CLBT

Earnings

Guidance Update

M&A

Cellebrite reported strong financial results for Q4 2025, with revenue of $128.8 million and Total Annual Recurring Revenue (ARR) of $480.8 million, representing year-over-year increases of 18% and 21% respectively. For the full-year 2025, revenue reached $475.7 million and subscription revenue was $427.0 million, up 19% and 21% year-over-year.
The company provided a positive financial outlook for 2026, projecting Full-Year 2026 ARR between $567 million and $573 million and revenue between $565 million and $571 million.
Strategic developments include the acquisition of Corellium in December 2025, contributing $16.1 million in ARR, and an agreement to acquire SCG Canada Inc. to enhance drone forensics capabilities. Cellebrite also increased its investment in AI and exceeded its Inseyets conversion target.

Feb 11, 2026, 12:00 PM

Press Release

Cellebrite Reports Q4 and Full-Year 2025 Results, Provides 2026 Outlook, and Details Corellium Acquisition

CLBT

Earnings

Guidance Update

M&A

Cellebrite reported Q4 2025 total revenue of $129 million, an 18% increase year-over-year, and subscription revenue of $115 million, up 21% year-over-year.
Annual Recurring Revenue (ARR) reached $481 million as of December 2025, marking a 21% year-over-year growth, with 17% organic expansion. This includes a $16.1 million contribution from the Corellium acquisition, which closed in Q4 2025 for $170 million in cash.
For fiscal year 2025, the company achieved $476 million in revenue, $127.6 million in Adjusted EBITDA, and a Free Cash Flow of $160.3 million with a 33.7% margin.
Cellebrite provided FY 2026 expectations, forecasting ARR between $567 million and $573 million, revenue between $565 million and $571 million, and Adjusted EBITDA between $149 million and $155 million.

Feb 11, 2026, 12:00 PM

Presentation

Cellebrite's 2026 Industry Trends Report Highlights Digital Evidence Shifts and Product Growth

CLBT

New Projects/Investments

Revenue Acceleration/Inflection

Cellebrite's 2026 Industry Trends Report, published on February 5, 2026, reveals that 97% of investigators cite smartphones as the top source of digital evidence, a significant increase from 73% in 2024.
The report indicates that 65% of public safety respondents believe AI can accelerate investigations, despite policy limitations, and cloud receptiveness for digital evidence management reached 42% in 2026, up from 38% in 2025.
Cellebrite's investigative platform, Guardian, achieved triple-digit year-over-year growth in 2025 across customers, users, and data stored, primarily among state and local law enforcement agencies, and was recently made available to enterprise customers.

Feb 5, 2026, 1:30 PM

Press Release

Cellebrite highlights strategic growth drivers and Corellium acquisition

CLBT

M&A

CEO Change

New Projects/Investments

Cellebrite's CEO, Tom Hogan, transitioned to permanent CEO after serving as interim, citing the company's mission and significant economic opportunity as key motivators.
The company announced the closing of its acquisition of Corellium, which virtualizes ARM-based devices, expanding Cellebrite's platform and growth opportunities, particularly in DevSecOps and pen testing.
Cellebrite anticipates a resurgence of growth in the U.S. federal sector in calendar 2026, driven by leadership stability, earmarked funds, and expected FedRAMP authorization for cloud products in Q1 2026.
The company is leveraging Artificial Intelligence (AI) to enhance its core products and develop agentic applications for digital investigations, aiming to improve efficiency and solve complex crimes while maintaining human oversight for legal traceability.
Cellebrite currently operates at a 30% free cash flow margin, with expectations for this to continue climbing, and identifies drivers for future ARR growth including new logos, platform selling, and adoption of key products like Inseyets, Guardian, and Pathfinder.

Dec 2, 2025, 9:15 PM

Transcript

Cellebrite discusses Corellium acquisition, CEO transition, and 2026 growth outlook

CLBT

M&A

CEO Change

Guidance Update

Cellebrite announced the closing of its acquisition of Corellium, which virtualizes Arm-based devices, expanding its platform and total addressable market (TAM).
CEO Tom Hogan confirmed his transition to full-time CEO after serving as interim, citing the company's mission and economic opportunity.
The company anticipates a resurgence of growth in the U.S. Federal sector in calendar 2026, driven by leadership stability, earmarked funds, and expected Level 4 FedRAMP certification in Q1 2026.
Cellebrite maintains a strong financial position, running at a 30% free cash flow margin and identifying multiple drivers for future ARR growth, including new logos, platform sales, and product adoption.
The company is leveraging AI internally for productivity and externally to enhance digital investigations, helping process vast amounts of evidence and accelerate case resolution.